Source: Eur Respir J 2009; 33: 354-360
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Brand P., Schulte M., Wencker M., Herpich C. H., Klein G., Hanna K., Meyer T.. Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J 2009; 33: 354-360

Member's Comments

No comment yet.

Related content which might interest you: Inhaled heparin in cystic fibrosis Source: Eur Respir J 2006; 27: 354-358 Year: 2006 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights Source: Eur Respir J 2009; 33: 475-488 Year: 2009 Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice Source: Eur Respir J 2011; 37: 72-78 Year: 2011 Long-term clearance from small airways in patients with cystic fibrosis Source: Eur Respir J 2005; 25: 317-323 Year: 2005 Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis Source: Eur Respir J 2002; 19: 294-302 Year: 2002 Pulmonary administration of alpha1-antitrypsin for the treatment of Alpha1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011 Alveolar nitric oxide correlates with lung volumes in patients with emphysema and Alpha-1 antitrypsin deficiency (AATD) Source: Eur Respir J 2006; 28: Suppl. 50, 223s Year: 2006 Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study Source: Eur Respir J 2005; 25: 62-68 Year: 2005 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis Source: Eur Respir J 2011; 37: 1091-1095 Year: 2011 Clinical features of alpha one antitrypsin deficiency in non cystic fibrosis bronchiectasis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Source: Eur Respir J 2002; 20: 122-126 Year: 2002 Inhalation therapy in cystic fibrosis Source: School Course 2013 - Cystic Fibrosis Year: 2013 Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis Source: Eur Respir J 2001; 18: 316-322 Year: 2001